This injectable treatment for wrinkles is made from the same neurotoxin (botulinum toxin type A) as Botox. Dysport (formally Reloxin) received the approval of the U.S. Food and Drug Administration (FDA) for use as a wrinkle treatment in the spring of 2009, but it has been smoothing out facial folds and lines in Europe, South America, and elsewhere for several years. Like Botox, this injectable was originally developed in the 1990s for the treatment of neuromuscular disorders.
Dysport is injected directly into the muscles that cause facial wrinkles, temporarily immobilizing them. It specifically targets the glabullar muscles — the ones that form creases on your forehead when you frown.
Dysport diffuses a bit farther from the injection point than Botox—one to three centimeters in comparison to Botox’s one centimeter. This means that fewer injections are needed, but it also means that the professional doing the injections must be very skilled to ensure that the drug does not spread to nearby muscles causing unwanted side effects.
This is a reason to feel assured that, at PRASAD Cosmetic Surgery, you will receive the expertise of Oculoplastic surgeon Dr. Amiya Prasad who has performed thousands of surgeries and specializes in cosmetic surgery of the eyes and face. He is a fellow of the American Society of Ophthalmic, Plastic & Reconstructive Surgery (Oculofacial Plastic Surgery) and The American Academy of Cosmetic Surgery.
Results begin to appear within one to seven days after treatment, with day three being the median. (In other words, half the patients treated see wrinkle-smoothing results before day three, and half see results afterwards.) Dysport contains less protein than Botox, so the body tends to break it down more slowly. The studies are mixed, however, about whether the results of Dysport lasts longer than Botox.
During your consultation, Dr. Amiya Prasad will answer any questions you may have regarding DYSPORT vs. BOTOX, as well as other procedures that can help you achieve your cosmetic goals.